T1	Outcomes 942 956	activated CECs
T2	Outcomes 1096 1121	disease progressive cases
T3	Outcomes 1222 1249	expression of survivin mRNA
T4	Outcomes 1315 1340	disease progressive cases
T5	Outcomes 1395 1409	activated CECs
T6	Outcomes 1662 1676	activated CECs
T7	Outcomes 1695 1720	time to progression (TTP)
T8	Outcomes 1790 1843	amount of survivin mRNA in serum post-therapy and TTP
